Daisy Lab Announces Major Breakthrough in Production of Bovine Lactoferrin Through Precision Fermentation
New Zealand-based precision fermentation company Daisy Lab has announced a major milestone in its work to produce bovine lactoferrin. After just over a year of research, Daisy Lab says it can now produce multiple grams per litre of bovine lactoferrin in a yeast host. This reportedly opens the door to the commercial-scale production of bioidentical lactoferrin for applications such as infant formula, functional foods, supplements, and nutraceuticals. Lactoferrin is described as a rare, bioactive protein with antimicrobial, anti-inflammatory, and immune-boosting properties. In cow’s milk, it occurs naturally at concentrations as low as 0.02–0.2 grams per litre, but Daisy Lab’s technology allows for much higher yields. As a result, precision fermentation-derived lactoferrin could offer a more sustainable, consistent, and abundant supply of the ingredient, with no …